NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

My guess is that NWBO and Germany already know the price point that is competitive, fair and consistent with their system. Like other drug companies, after launch, cost savings from economy of scale will become very critical. That brings us back to the large expansion in manufacturing capability NWBO recently financed. We also must remember the cost savings this medication will bring to Europe based upon overall reduced hospital time, reduced loss of work and reduced government costs -- especially if cost-effective treatments like they are using in Cologne replace adjunct chemotherapy as the superior combination with DCVAX-L.

If Ou is correct, and German approval for compassionate use is de facto commercial market approval for Germany, then the time NWBO spends getting FDA and EMA approval will be effectively partially compensated by the German, British and Israeli Compassionate Use reimbursements. NWBO will also save administrative costs in avoiding endless country by country price negotiations.